The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.
نویسندگان
چکیده
Co-chairs: David Feldman, MD, PhD; Salpy V Pamboukian, MD, MSPH; Jeffrey J. Teuteberg, MD; Task Force Chairs (exclusive of co-authors): Emma Birks, MD; Katherine Lietz, MD; Stephanie A. Moore, MD; Jeffrey A. Morgan, MD Contributing Writers (exclusive of co-chairs or chairs): Francisco Arabia, MD; Mary E. Bauman, MScN, NP; Hoger W. Buchholz, MD; Mario Deng, MD; Marc L. Dickstein, MD; Aly El-Banayosy, MD; Tonya Elliot, RN, MSN; Daniel J. Goldstein, MD; Kathleen L. Grady, PhD, APN; Kylie Jones, RN; Katarzyna Hryniewicz, MD; Ranjit John, MD; Annemarie Kaan, MCN, RN; Shimon Kusne, MD; Matthias Loebe, MD, PhD; M. Patricia Massicotte, MHSc, MD; Nader Moazami, MD; Paul Mohacsi, MD; Martha Mooney, MD; Thomas Nelson, MD; Francis Pagani, MD; William Perry, RN; Evgenij V. Potapov, MD; J. Eduardo Rame, MD, MPhil; Stuart D. Russell, MD; Erik N. Sorensen, PhD; Benjamin Sun, MD; and Martin Strueber, MD Independent Reviewers: Abeel A. Mangi, MD; Michael G. Petty, PhD,RN; and Joseph Rogers, MD.
منابع مشابه
The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary.
Shahid Husain, MD, MS, Amparo Sole, MD, PhD, Barbara D. Alexander, MD, MHS, Saima Aslam, MD, MS, Robin Avery, MD, Christian Benden, MD, Eliane M. Billaud, PharmD, PhD, Daniel Chambers, MBBS, MD, Lara Danziger-Isakov, MD, Savitri Fedson, MD, Kate Gould, MD, Aric Gregson, MD, Paolo Grossi, MD, PhD, Denis Hadjiliadis, MD, Peter Hopkins, MD, Me-Linh Luong, MD, Debbie J.E. Marriott, MD, Victor Monfo...
متن کاملMechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report--2004.
متن کامل
Present status and future perspectives of heart transplantation.
Heart transplantation has evolved as the "gold standard" therapy, with median survival exceeding 10 years, for patients with endstage heart failure (HF). Advancements in the fields of immunosuppression, infection prophylaxis, and surgical techniques have transformed heart transplantation from what was once considered an experimental intervention into a routine treatment. The number of heart tra...
متن کاملPre-Transplant Therapy in Experimental Heart Transplantation
Heart transplantation is a life-saving procedure for patients with end-stage cardiac dysfunction. Currently one-year graft survival ranges between 77-88%, three-year survival between 77-79% and five-year survival between 67-73% (http://www.americanheart.org/presenter.jhtml?identifier=4588). Despite these encouraging results, primary graft failure accounts for about 23% of deaths in the first 90...
متن کاملReport of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.
To evaluate cardiac retransplantation as an appropriate utilization of scarce donor organs we analyzed data from the registry of the International Society for Heart and Lung Transplantation (ISHLT) (n = 449) and the Utah Cardiac Transplant Program (n = 20). Actuarial survival among retransplants was lower than in patients who received only one transplant in both the ISHLT registry patients (1 y...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
دوره 32 2 شماره
صفحات -
تاریخ انتشار 2013